Koppers
Koppers' revenue fell 10.2% to $1.9 billion in fiscal 2025. Its operating margin was 8.9%, up from 7.1% a year earlier. Free cash flow was $68 million, up 60.7%. It paid out $45 million in dividends and buybacks, 66% of free cash flow. The diluted share count fell 4.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share grew 7.8% a year and net income 7.5% a year, as buybacks cut the share count by 3%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Koppers yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Koppers' 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Koppers' fiscal 2025 free cash flow of $68M, net cash of −$890M at December 31, 2025 and 20 million diluted shares, from its filings. The scenarios are fitted to Koppers: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -1.7% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 13%: 11% for a cyclical or higher-risk business (Commodity Chemicals), plus 1 point as a smaller company, worth $761M, plus 1 point for unsteady results (revenue fell in two of the last five years); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target. A negative value means Koppers' net debt is larger than what that scenario's cash flows are worth today.
- Last close, October 26, 2026
- $39.83
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
The P/E method needs positive earnings, and Koppers' latest diluted earnings per share were negative or zero.
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 46 | 33 | 66 | 44 | 38 |
| Debt incl. finance leases | 789 | 825 | 849 | 940 | 928 |
| Net debt (negative means net cash) | 744 | 792 | 783 | 896 | 890 |
| Net debt to EBITDA | 3.5x | 4.1x | 3.1x | 4.2x | 3.7x |
| Debt to equity | 1.9x | 2.1x | 1.7x | 1.9x | 1.6x |
| Interest coverage | 3.9x | 3.1x | 2.8x | 1.9x | 2.5x |
| Current ratio | 2.2x | 2.0x | 2.1x | 2.1x | 2.9x |
| Quick ratio | 1.1x | 0.9x | 0.9x | 0.8x | 1.1x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Koppers shares on the open market, and 4 insiders sold $5.6 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Ball M LeroyCEO, Director | Sold | 4,000 | $45.96 | $183,840 | Form 4 |
| Aug 19, 2026 | Ball M LeroyCEO, Director | Sold | 3,000 | $45.84 | $137,520 | Form 4 |
| Aug 12, 2026 | Stephen G LucasSVP, Culture and Engagement | Sold | 1,308 | $44.55 | $58,271 | Form 4 |
| Aug 11, 2026 | James A. SullivanPresident and CTO | Sold | 7,500 | $50.00 | $375,000 | Form 4 |
| Aug 10, 2026 | Bradley A PearceCAO | Sold | 2,000 | $51.01 | $102,020 | Form 4 |
| Aug 7, 2026 | James A. SullivanPresident and CTO | Sold | 80,000 | $50.01 | $4.0 million | Form 4 |
| Jun 18, 2026 | Ball M LeroyCEO, Director | Sold | 3,412 | $43.90 | $149,787 | Form 4 |
| Jun 11, 2026 | Ball M LeroyCEO, Director | Sold | 4,141 | $41.34 | $171,189 | Form 4 |
| May 13, 2026 | Ball M LeroyCEO, Director | Sold | 2,659 | $42.55 | $113,140 | Form 4 |
| Mar 17, 2026 | Ball M LeroyCEO, Director | Sold | 2,489 | $37.91 | $94,358 | Form 4 |
| Mar 2, 2026 | Ball M LeroyCEO, Director | Sold | 6,275 | $36.87 | $231,371 | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Pass |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Pass | Fail | Pass |
| Share count didn't rise | Fail | Pass | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Fail | Fail |
| F-score | 8 of 9 | 5 of 9 | 8 of 9 |
| Accruals ratio | −3.2% | −3.6% | −3.5% |
Compare
Put Koppers side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Koppers | FY25 | −10.2% | 8.9% | 3.6% | 8.1% | 3.7x | 8 | |
| Hawkins | FY26 | 11.2% | 11.2% | 7.9% | 13.1% | 1.4x | 4 | Compare |
| Dow | FY25 | −7.0% | — | −3.6% | −4.1% | 12.0x | 3 | Compare |
| Quaker Chemical | FY25 | 2.7% | 2.8% | 4.3% | 1.3% | 6.1x | 5 | Compare |
| Ashland Global | FY25 | −13.7% | −42.5% | 2.0% | −17.5% | — | 5 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,416 | 1,476 | 1,563 | 1,637 | 1,669 | 1,679 | 1,980 | 2,154 | 2,092 | 1,879 |
| Revenue growth | −12.9% | 4.2% | 5.9% | 4.8% | 2.0% | 0.6% | 18.0% | 8.8% | −2.9% | −10.2% |
| Gross profit | 290 | 322 | 302 | 331 | 360 | 334 | 345 | 424 | 423 | 448 |
| Research and development | 7 | 9 | — | — | — | — | — | — | — | — |
| Operating income | 93 | 124 | 84 | 125 | 157 | 156 | 138 | 195 | 148 | 168 |
| Net income | 29 | 29 | 23 | 67 | 122 | 85 | 63 | 89 | 52 | 56 |
| Diluted EPS (US$) | 1.39 | 1.32 | 1.10 | 3.16 | 5.71 | 3.88 | 2.98 | 4.14 | 2.46 | 2.74 |
| Diluted shares (millions) | 21 | 22 | 21 | 21 | 21 | 22 | 21 | 22 | 21 | 20 |
| Cash flow | ||||||||||
| Cash from operations | 120 | 102 | 78 | 115 | 127 | 103 | 102 | 146 | 119 | 122 |
| Capital expenditure | 50 | 68 | 110 | 37 | 70 | 125 | 105 | 120 | 77 | 55 |
| Free cash flow | 70 | 34 | −31 | 78 | 57 | −22 | −3 | 26 | 42 | 68 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 5 | 6 | 6 |
| Share buybacks | 0 | 5 | 32 | 1 | 2 | 12 | 24 | 20 | 51 | 38 |
| Acquisitions | 0 | 0 | 264 | 0 | 0 | 0 | 15 | 0 | 99 | 21 |
| Stock-based compensation | 9 | 11 | 12 | 12 | 11 | 13 | 13 | 17 | 21 | 14 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 21 | 51 | 37 | 32 | 38 | 46 | 33 | 66 | 44 | 38 |
| Debt incl. finance leases | 671 | 689 | 1,003 | 912 | 784 | 789 | 825 | 849 | 940 | 928 |
| Total assets | 1,088 | 1,200 | 1,480 | 1,565 | 1,599 | 1,662 | 1,711 | 1,836 | 1,890 | 1,887 |
| Total liabilities | 1,053 | 1,094 | 1,413 | 1,406 | 1,253 | 1,251 | 1,308 | 1,332 | 1,401 | 1,312 |
| Shareholders' equity | 30 | 100 | 56 | 147 | 342 | 407 | 399 | 499 | 489 | 574 |
| Margins and ratios | ||||||||||
| Gross margin | 20.5% | 21.8% | 19.3% | 20.2% | 21.6% | 19.9% | 17.4% | 19.7% | 20.2% | 23.8% |
| Operating margin | 6.6% | 8.4% | 5.4% | 7.6% | 9.4% | 9.3% | 7.0% | 9.1% | 7.1% | 8.9% |
| Net margin | 2.1% | 2.0% | 1.5% | 4.1% | 7.3% | 5.1% | 3.2% | 4.1% | 2.5% | 3.0% |
| Free cash flow margin | 4.9% | 2.3% | −2.0% | 4.8% | 3.4% | −1.3% | −0.1% | 1.2% | 2.0% | 3.6% |
| Return on capital | 9.5% | 9.0% | 4.8% | 12.1% | 11.9% | 9.9% | 7.8% | 11.3% | 7.8% | 8.1% |
| Return on equity | — | 44.7% | 30.0% | 65.5% | 49.9% | 22.8% | 15.7% | 19.9% | 10.6% | 10.5% |
| Return on assets | 2.7% | 2.5% | 1.8% | 4.4% | 7.7% | 5.2% | 3.8% | 5.0% | 2.8% | 3.0% |
| Net debt to EBITDA | 4.4x | 3.7x | 7.3x | 5.0x | 3.5x | 3.5x | 4.1x | 3.1x | 4.2x | 3.7x |